TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SBRA

Sabra Healthcare REIT Inc

Real Estate · REIT - Healthcare Facilities

20.20$ +0.3% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Sabra Healthcare REIT Inc (SBRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.4% of the shares are freely tradable; institutional investors hold 108.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 108.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 256Mio.

Largest Shareholders

Institutions

Institutions SBRA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.30 39,098,389 +1.8 03/31/2026
Principal Financial Group Inc 9.67 24,706,070 -1.4 06/30/2026
Vanguard Portfolio Management, LLC 9.06 23,143,248 +0.0 03/31/2026
State Street Corp 4.74 12,099,951 +1.7 03/31/2026
Vanguard Capital Management, LLC 4.40 11,230,748 +0.0 03/31/2026
JPMorgan Chase & Co 3.21 8,201,220 +211.6 03/31/2026

Funds

Funds SBRA
Name Stake (%) Shares Change (%) Date
Vanguard Real Estate Index Investor 3.76 9,592,677 +0.0 07/31/2026
iShares Core S&P Mid-Cap ETF 3.46 8,832,004 +0.0 08/31/2026
Principal Real Estate Securities R5 3.24 8,264,998 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.14 8,032,098 +0.4 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings SBRA
Person Role Shares Value As of Type
Matros Richard K Chair, CEO and President 2,613,954 52,801,871 $ Aug 31, 2026 both
Costa Michael Lourenco Executive VP, CFO & Treasurer 469,879 9,491,556 $ Aug 31, 2026 direct
Malehorn Jeffrey A. Director 117,137 2,366,167 $ Aug 31, 2026 direct
Smith Darrin Executive VP, CIO & Secretary 116,919 2,361,764 $ Aug 31, 2026 direct
Katzmann Lynne S Director 86,912 1,755,622 $ Aug 31, 2026 direct
Cusack Catherine Director 82,847 1,673,509 $ Aug 31, 2026 direct
Foster Michael J Director 82,834 1,673,247 $ Aug 31, 2026 direct
Flores Jessica Executive VP & CAO 72,476 1,464,015 $ Aug 31, 2026 direct
Kono Ann Director 68,977 1,393,335 $ Aug 31, 2026 direct
Barbarosh Craig A. Director 54,580 1,102,516 $ Aug 31, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 8, 2026 Matros Richard K Chair, CEO and President Sell 200,000 20.83 4,166,000
Aug 31, 2026 Smith Darrin Executive VP, CIO & Secretary Other 495 0.00
Aug 31, 2026 Flores Jessica Executive VP & CAO Other 382 0.00
Aug 31, 2026 Cusack Catherine Director Other 791 0.00
Aug 31, 2026 Costa Michael Lourenco Executive VP, CFO & Treasurer Other 4,158 0.00
Aug 31, 2026 Kono Ann Director Other 791 0.00
Aug 31, 2026 Katzmann Lynne S Director Other 791 0.00
Aug 31, 2026 Malehorn Jeffrey A. Director Other 791 0.00
Aug 31, 2026 Barbarosh Craig A. Director Other 791 0.00
Aug 31, 2026 Matros Richard K Chair, CEO and President Other 13,867 0.00
Aug 31, 2026 Foster Michael J Director Other 791 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?